🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: short acting β2- agonist

Found 39 matching trials

1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)

PHASE3

This study was designed to investigate the 1 year efficacy and safety of th...

Status

Completed

Location

Novartis Investigative Site

Start Date

2009-06

Trial ID

NCT00929110

Treatments Being Tested

Glycopyrronium bromide Placebo to glycopyrronium bromide Tiotropium

Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)

PHASE2

The study was designed to obtain data about the efficacy and safety of 3 do...

Status

Completed

Location

Novartis Investigative site

Start Date

2006-12

Trial ID

NCT00403845

Treatments Being Tested

Indacaterol 150 μg Indacaterol 300 μg Placebo

Effect of Indacaterol on Inspiratory Capacity (IC)

PHASE3

This study is being conducted to assess the effect of indacaterol (150 μg o...

Status

Completed

Location

Novartis Investigative Site

Start Date

2009-11

Trial ID

NCT01012765

Treatments Being Tested

Indacaterol Tiotropium Placebo

Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma

PHASE4

This study investigated asthma-related quality of life in Brazilian patient...

Status

Completed

Location

Novartis Investigator Site

Start Date

2007-11

Trial ID

NCT00567476

Treatments Being Tested

Omalizumab Inhaled corticosteroids (ICS)Long-acting beta 2-adrenergic agonist (LABA)Short-acting beta 2-adrenergic agonist (SABA)

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

PHASE2

The primary objective of this study is to evaluate the dose response, effic...

Status

Completed

Location

Teva Investigational Site 10453

Start Date

2013-01

Trial ID

NCT01772368

Treatments Being Tested

Fp MDPI FS MDPI Advair Diskus Albuterol

Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices

PHASE2

This study assessed the efficacy, safety, tolerability, and pharmacokinetic...

Status

Completed

Location

Novartis Investigative Site

Start Date

2009-10

Trial ID

NCT01012739

Treatments Being Tested

Indacaterol 150 μg via the Concept1 dry-powder inhaler Indacaterol 60 μg via the Simoon dry-powder inhaler Indacaterol 120 μg via the Simoon dry-powder inhaler Placebo to indacaterol via the Concept1 dry-powder inhaler

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen

PHASE4

The main goal of this study is to evaluate the efficacy and safety of glyco...

Status

Completed

Location

Novartis Investigative Site

Start Date

2014-02-14

Trial ID

NCT01985334

Treatments Being Tested

Glycopyrronium SABA LABA Indacaterol maleate and glycopyrronium bromide LAMA SAMA ICS

Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease

PHASE3

This study will assess the efficacy, tolerability and safety of NVA237 comp...

Status

Completed

Location

Novartis Investigative Site

Start Date

2012-04

Trial ID

NCT01513460

Treatments Being Tested

NVA237 50µg once daily Tiotropium 18µg once daily Flu/Sal NVA237 placebo + Tiotropium placebo.

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

PHASE3

This study assessed the efficacy and safety of indacaterol (150 µg once dai...

Status

Completed

Location

Novartis Investigator Site

Start Date

2009-03

Trial ID

NCT00846586

Treatments Being Tested

Indacaterol 150 μg Tiotropium 18 μg Placebo to indacaterol

Acute Effect of Salbutamol on Heart Rate and Blood Pressure During Exercise in Patients With Moderate or Severe Asthma and Healthy Subjects

PHASE4

Contextualization: Exercise is a common triggers of bronchospasm in patient...

Status

Completed

Location

Jaqueline Ribas de Melo

Start Date

2016-08-06

Trial ID

NCT03044938

Treatments Being Tested

salbutamol Placebo

Previous Next